Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cheryl L. Maier
Using an Old Test for New Tricks: Measuring Direct Oral Anti-Xa Drug Levels by Conventional Heparin-Calibrated Anti-Xa Assay
American Journal of Hematology
Hematology
Related publications
Rivaroxaban: An Oral Direct Inhibitor of Factor Xa
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Antithrombotic Drug and Its Clinical Indication. Factor Xa Inhibitor. Oral Xa Inhibitor (DX-9065a).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
A Retrospective Analysis of Correlation Between APTT and Anti-Xa Levels Using Ex Vivo Plasma Samples From Patients on Intravenous Heparin Therapy
Pathology
Forensic Medicine
Pathology
Current Status and Future of Anti-Xa Inhibitors
Clinical Neurology
Neurology
Interlaboratory Agreement in the Monitoring of Unfractionated Heparin Using the Anti-Factor Xa-Correlated Activated Partial Thromboplastin Time
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Fibrin-Targeted Direct Factor Xa Inhibition: Construction and Characterization of a Recombinant Factor Xa Inhibitor Composed of an Anti-Fibrin Single-Chain Antibody and Tick Anticoagulant Peptide
Thrombosis and Haemostasis
Hematology
Ixolaris: A Factor Xa Heparin-Binding Exosite Inhibitor
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor
Clinical Pharmacology: Advances and Applications
Pharmacology
Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa Inhibitors
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
